Brazil Veterinary Medicine Market Growth & Trends
The Brazil veterinary medicine market size is expected to reach USD 4.15 billion by 2030, registering a CAGR of 7.9% from 2025 to 2030, according to a new report by Grand View Research, Inc. The rising pet ownership rate, increased livestock production, and growing demand for advanced veterinary pharmaceuticals and vaccines drive market growth. Expanding government initiatives to improve animal health and the increasing presence of veterinary medicine providers further contribute to market expansion. Advancements in veterinary drug formulations and efforts to enhance disease prevention strategies are also supporting market growth. The growing emphasis on animal welfare and improved access to veterinary healthcare solutions is expected to drive further adoption of veterinary medicines across Brazil.
Brazil is one of the world’s largest exporters of beef and poultry, and this status encourages farmers to adopt rigorous health management practices, including regular veterinary care, vaccination, and disease prevention measures, to ensure high-quality animal protein output. According to the OECD, in 2023, Brazil's beef and veal meat consumption was projected to reach 18.1 kg per person, as compared to 17.8 kg per person in 2022. As demand for meat rises, livestock production scales up, requiring improved animal health practices to ensure meat quality and safety standards. Moreover, producers are motivated to invest in animal health to ensure that livestock remains free from diseases and meets the standards for both local consumption and export. This focus on preventive and therapeutic veterinary care further stimulates market growth as producers seek solutions to maintain animal welfare, improve feed efficiency, and reduce mortality rates.
Furthermore, the growth of veterinary healthcare facilities, including new animal clinics and specialized care centers, strengthens the Brazil Veterinary Medicine Market. Better access to veterinary services and improved diagnostic tools are helping detect diseases early and provide effective treatments. In addition, a stronger focus on sustainable livestock management and responsible use of antibiotics is driving the adoption of eco-friendly veterinary solutions. These trends are shaping the market and supporting its continued growth.
Request a free sample copy or view report summary: Brazil Veterinary Medicine Market Report
Brazil Veterinary Medicine Market Report Highlights
By product, pharmaceuticals dominated the market with a share of 67.58% in 2024. However, the biologics segment is expected to grow at the highest CAGR of 8.8% during the forecast period. This growth is driven by increasing demand for vaccines and immunotherapies, along with advancements in biotechnology improving disease prevention and treatment in animals.
By animal type, production animals held the largest market share in 2024, driven by the growing demand for livestock healthcare and disease management solutions. However, the companion animals segment is expected to grow at the fastest CAGR during the forecast period. This growth is supported by the rising pet population, increasing pet healthcare awareness, and a greater focus on preventive treatments for household animals.
By route of administration, the injectable segment held the largest market share in 2024 due to its effectiveness in delivering fast-acting treatments for both companion and production animals. However, the other routes segment, including intranasal delivery, controlled-release implants, and transdermal patches, is expected to grow the most during the forecast period. This growth is driven by the increasing adoption of alternative drug delivery methods that enhance convenience, reduce animal stress, and improve treatment adherence.
By distribution channel, veterinary hospitals and clinics held the largest market share in 2024. The e-commerce segment is expected to grow at the highest CAGR, driven by the convenience and accessibility of online veterinary products.
Brazil Veterinary Medicine Market Segmentation
Grand View Research has segmented the Brazil veterinary medicine market based on product, animal type, route of administration, and distribution channel:
Brazil Veterinary Medicine Product Outlook (Revenue, USD Million, 2018 - 2030)
Biologics
Vaccines
Modified/ Attenuated Live
Inactivated (Killed)
Other Vaccines (subunit and DNA vaccines)
Other Biologics (monoclonal antibodies and regenerative medicine)
Pharmaceuticals
Parasiticides
Anti-infectives
Anti-inflammatory
Analgesics
Others (cardiology, neurology, and hormone/fertility pharmaceuticals)
Medicated Feed Additives
Brazil Veterinary Medicine Animal Type Outlook (Revenue, USD Million, 2018 - 2030)
Production Animals
Poultry
Pigs
Cattle
Sheep & Goats
Others (aquaculture/fish, mules, camel, etc.)
Companion Animals
Dogs
Cats
Horses
Others (small mammals, birds, rabbits, reptiles, etc.)
Brazil Veterinary Medicine Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
Oral
Injectable
Topical
Other Routes (intranasal, controlled-release implants, etc.)
Brazil Veterinary Medicine Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
Veterinary Hospitals & Clinics
E-commerce
Offline Retail Stores
Others
List of Key Players in Brazil Veterinary Medicine Market
Zoetis Services LLC
Ceva
Merck & Co., Inc.
Vetoquinol
Boehringer Ingelheim International GmbH.
Elanco
Virbac
Phibro Animal Health Corporation
Dechra Pharmaceuticals limited (Dechra Topco Limited)
Bimeda, Inc.
Biogénesis Bagó
Ourofino Saúde Animal
FARMABASE
Vetnil
Alivira Animal Health Limited
